Afon Technology’s Glucowear™ device has achieved approximately 75 per cent overall accuracy in distinguishing between normal and elevated blood glucose levels during its first, real-world trial. ...
The world’s first fully closed-loop feature will become available within the existing CamAPS® FX app. In a pioneering move for type 1 diabetes care, CamDiab’s new CamAPS Liberty feature will ...
An educational conference uniting cardiovascular, renal and metabolic care has strengthened its leadership team, reinforcing its commitment to delivering a new era of “smart healthcare”. Matt ...
Eleanor Cross Healthcare in Northampton has secured funding from the National Institute for Health and Care Research (NIHR) Capital Investment Programme to establish a dedicated primary care ...
